{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:47:37Z","timestamp":1792802857102,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100013516","name":"Community Foundation for the Greater Capital Region","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013516","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition Research"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.nutres.2020.05.007","type":"journal-article","created":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T21:39:14Z","timestamp":1589837954000},"page":"93-104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Lower concentrations of curcumin inhibit Her2-Akt pathway components in human breast cancer cells, and other dietary botanicals potentiate this and lapatinib inhibition"],"prefix":"10.1016","volume":"78","author":[{"given":"Abhinav R","family":"Saxena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoran","family":"Ilic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veda","family":"Sripada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana R.","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nutres.2020.05.007_bb0005","unstructured":"Howlader N, Noone AM, Krapcho M, Miller D, Brest A, Yu M et al (eds). SEER Cancer Statistics Review, 1975\u20132017, National Cancer Institute. Bethesda, MD, https:\/\/seer.cancer.gov\/csr\/1975_2017\/; 2020."},{"key":"10.1016\/j.nutres.2020.05.007_bb0010","unstructured":"American Cancer Society. Cancer Facts and Figures, https:\/\/www.cancer.org\/content\/dam\/cancer-org\/research\/cancer-facts-and-statistics\/annual-cancer-facts-and-figures\/2019\/cancer-facts-and-figures-2019.pdf"},{"key":"10.1016\/j.nutres.2020.05.007_bb0015","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41374-018-0033-8","article-title":"The extracellular domain of Her2 in serum as a biomarker of breast cancer","volume":"98","author":"Perrier","year":"2018","journal-title":"Lab Invest"},{"key":"10.1016\/j.nutres.2020.05.007_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/743193","article-title":"The HER2 receptor in breast Cancer: pathophysiology, clinical use, and new advances in therapy","volume":"2012","author":"Mitri","year":"2012","journal-title":"Chemother Res Prac"},{"key":"10.1016\/j.nutres.2020.05.007_bb0025","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3390\/antiox6040088","article-title":"Polyphenols as promising drugs against Main breast Cancer signatures","volume":"6","author":"Losada-Echeberr\u00eda","year":"2017","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.nutres.2020.05.007_bb0030","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1016\/j.ejca.2008.09.013","article-title":"Her2-positive breast cancer: Herceptin and beyond","volume":"44","author":"Dean-Colomb","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.nutres.2020.05.007_bb0035","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ctrv.2018.04.016","article-title":"Treatment of advanced HER2-positive breast cancer: 2018 and beyond","volume":"67","author":"Pond\u00e9","year":"2018","journal-title":"Cancer Treat Rev"},{"issue":"7","key":"10.1016\/j.nutres.2020.05.007_bb0040","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1080\/14737140.2018.1477596","article-title":"Combination therapies for the treatment of HER2-positive breast cancer: current and future prospects","volume":"18","author":"Brand\u00e3o","year":"2018","journal-title":"Expert Rev Anticancer Ther"},{"issue":"16","key":"10.1016\/j.nutres.2020.05.007_bb0045","doi-asserted-by":"crossref","first-page":"6633","DOI":"10.18632\/oncotarget.1955","article-title":"ADAM10 mediates trastuzumab resistance and is correlated with survival in HER2 positive breast cancer","volume":"5","author":"Feldinger","year":"2014","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.nutres.2020.05.007_bb0050","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.nutres.2009.08.003","article-title":"Select phytochemicals suppress human T-lymphocytes and mouse splenocytes suggesting their use in autoimmunity and transplantation","volume":"29","author":"Hushmendy","year":"2009","journal-title":"Nutr Res"},{"issue":"5","key":"10.1016\/j.nutres.2020.05.007_bb0055","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.nutres.2015.02.007","article-title":"Fish oil improves gene targets of down syndrome in C57BL and BALB\/c mice","volume":"35","author":"Zmijewski","year":"2015","journal-title":"Nutr Res"},{"key":"10.1016\/j.nutres.2020.05.007_bb0060","doi-asserted-by":"crossref","first-page":"728","DOI":"10.3390\/nu9070728","article-title":"Dietary natural products for prevention and treatment of breast Cancer","volume":"9","author":"Li","year":"2017","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.nutres.2020.05.007_bb0065","first-page":"43","volume":"34","author":"Menendez","year":"2009","journal-title":"Int J Oncol"},{"key":"10.1016\/j.nutres.2020.05.007_bb0070","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ejmech.2018.12.016","article-title":"The therapeutic potential of curcumin: a review of clinical trials","volume":"163","author":"Salehi","year":"2019","journal-title":"Eur J Med Chem"},{"issue":"6","key":"10.1016\/j.nutres.2020.05.007_bb0075","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.3390\/ijms19061716","article-title":"The role of Curcumin in prevention and Management of Metastatic Disease","volume":"19","author":"Bachmeier","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nutres.2020.05.007_bb0080","first-page":"105","article-title":"Curcumin induces apoptosis in breast cancer cell lines and delays the growth of mammary tumors in neu transgenic mice","volume":"27","author":"Masuelli","year":"2013","journal-title":"J Biol Regul Homeost Agents"},{"key":"10.1016\/j.nutres.2020.05.007_bb0085","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13046-017-0566-5","article-title":"Curcumin: the spicy modulator of breast carcinogenesis","volume":"36","author":"Banik","year":"2017","journal-title":"J Exp Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.nutres.2020.05.007_bb0090","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/ijc.31947","article-title":"Chemopreventive and therapeutic potential of curcumin in esophageal cancer: current and future status","volume":"144","author":"Hesari","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.nutres.2020.05.007_bb0095","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.fshw.2018.06.001","article-title":"Anticancer effect of curcumin on breast cancer and stem cells","volume":"7","author":"Liu","year":"2018","journal-title":"Food Sci Human Wellness"},{"key":"10.1016\/j.nutres.2020.05.007_bb0100","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1042\/CS20160935","article-title":"Curcumin mediates anticancer effects by modulating multiple cell signaling pathways","volume":"131","author":"Kunnumakkara","year":"2017","journal-title":"Clin Sci"},{"key":"10.1016\/j.nutres.2020.05.007_bb0105","first-page":"1","article-title":"Natural compounds as potential adjuvants to cancer therapy: preclinical evidence","volume":"2019","author":"Lin","year":"2019","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.nutres.2020.05.007_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/891893","article-title":"The potential utility of Curcumin in the treatment of HER-2-overexpressed breast Cancer: An in vitro and in vivo comparison study with Herceptin","volume":"2012","author":"Lai","year":"2012","journal-title":"Evid Based Complement Alternat Med"},{"issue":"2","key":"10.1016\/j.nutres.2020.05.007_bb0115","doi-asserted-by":"crossref","first-page":"158","DOI":"10.30699\/ijp.2017.24874","article-title":"The HER-2 as a target gene of Curcumin to protect hepatocytes against the arsenic-induced carcinoma in mice","volume":"12","author":"Ahadi","year":"2017","journal-title":"Iran J Pathol"},{"issue":"6","key":"10.1016\/j.nutres.2020.05.007_bb0120","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/ibd.20348","article-title":"Protective effects of dietary curcumin in mouse model of chemically induced colitis are strain dependent","volume":"14","author":"Billerey-Larmonier","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.nutres.2020.05.007_bb0125","series-title":"Curry powder to clinical significance","first-page":"69","article-title":"Curcumin C3 complex in completed clinical trials","author":"Majeed","year":"2015"},{"key":"10.1016\/j.nutres.2020.05.007_bb0130","doi-asserted-by":"crossref","unstructured":"Hewlings, Susan J and Douglas S Kalman. Curcumin: A Review of Its' Effects on Human Health. Foods (Basel, Switzerland) 2017; 6:92\u2013103.","DOI":"10.3390\/foods6100092"},{"issue":"5","key":"10.1016\/j.nutres.2020.05.007_bb0135","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1021\/acs.jmedchem.6b00975","article-title":"The essential medicinal chemistry of Curcumin: Miniperspective","volume":"60","author":"Nelson","year":"2017","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.nutres.2020.05.007_bb0140","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/biof.1042","article-title":"Curcumin uptake and metabolism","volume":"9","author":"Metzler","year":"2013","journal-title":"Biofactors"},{"issue":"1","key":"10.1016\/j.nutres.2020.05.007_bb0145","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1124\/jpet.108.137455","article-title":"Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer\u2019s disease","volume":"326","author":"Begum","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.nutres.2020.05.007_bb0150","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1208\/s12248-017-0177-2","article-title":"In vitro-in vivo dose response of Ursolic acid, Sulforaphane, PEITC, and Curcumin in Cancer prevention","volume":"20","author":"Ramirez","year":"2017","journal-title":"AAPS J"},{"key":"10.1016\/j.nutres.2020.05.007_bb0155","first-page":"1","article-title":"How does curcumin work with poor bioavailability? Clues from experimental and theoretical studies","volume":"6","author":"Shen","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.nutres.2020.05.007_bb0160","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/mnfr.201300724","article-title":"The oral bioavailability of curcumin from micronized powder and liquid micelles is significantly increased in healthy humans and differs between sexes","volume":"58","author":"Schiborr","year":"2014","journal-title":"Mol Nutr Food Res"},{"issue":"4B","key":"10.1016\/j.nutres.2020.05.007_bb0165","first-page":"2895","article-title":"Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions","volume":"21","author":"Cheng","year":"2001","journal-title":"Anticancer Res"},{"issue":"6","key":"10.1016\/j.nutres.2020.05.007_bb0170","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1007\/s00280-013-2151-8","article-title":"A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin) in cancer patients","volume":"71","author":"Kanai","year":"2013","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.nutres.2020.05.007_bb0175","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ccr.2006.10.008","article-title":"A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes","volume":"10","author":"Neve","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.nutres.2020.05.007_bb0180","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/mnfr.200700002","article-title":"Berry anthocyanins as novel antioxidants in human health and disease prevention","volume":"51","author":"Zafra-Stone","year":"2007","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.nutres.2020.05.007_bb0185","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1207\/s15327914nc5401_11","article-title":"Bilberry extracts induce gene expression through the electrophile response element","volume":"54","author":"Myhrstad","year":"2006","journal-title":"Nutr Cancer"},{"key":"10.1016\/j.nutres.2020.05.007_bb0190","first-page":"75","article-title":"Anti-angiogenic, antioxidant, and anti-carcinogenic properties of a novel anthocyanin-rich berry extract formula","volume":"69","author":"Bagchi","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.nutres.2020.05.007_bb0195","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s11010-006-1030-6","article-title":"Safety and whole-body antioxidant potential of a novel anthocyanin-rich formulation of edible berries","volume":"281","author":"Bagchi","year":"2006","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.nutres.2020.05.007_bb0200","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.nutres.2020.05.007_bb0205","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/carcin\/bgx048","article-title":"Characterization of liver injury, oval cell proliferation and cholangiocarcinogenesis in glutathione S-transferase A3 knockout mice","volume":"38","author":"Crawford","year":"2017","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.nutres.2020.05.007_bb0210","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.freeradbiomed.2019.07.019","article-title":"Control (native) and oxidized (DeMP) mitochondrial RNA are proinflammatory regulators in human","volume":"143","author":"Ilic","year":"2019","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"10.1016\/j.nutres.2020.05.007_bb0215","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1006\/abbi.1996.0202","article-title":"Oxidant-inducible adapt 15 RNA is associated with growth arrest- and DNA damage-inducible gadd153 and gadd45","volume":"329","author":"Crawford","year":"1996","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.nutres.2020.05.007_bb0220","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10549-018-05081-z","article-title":"Lapatinib activity in metastatic human epidermal growth factor receptor 2-positive breast cancers that received prior therapy with trastuzumab, pertuzumab, and\/or ado-trastuzumab emtansine (T-DM1)","volume":"176","author":"Baez-Vallecillo","year":"2019","journal-title":"Breast Cancer Res Treat"},{"issue":"12","key":"10.1016\/j.nutres.2020.05.007_bb0225","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1002\/jcb.24611","article-title":"Autophagy stimulates apoptosis in HER2-overexpressing breast cancers treated by lapatinib","volume":"114","author":"Zhu","year":"2013","journal-title":"J Cell Biochem"},{"issue":"17","key":"10.1016\/j.nutres.2020.05.007_bb0230","doi-asserted-by":"crossref","first-page":"5123","DOI":"10.1158\/1078-0432.CCR-16-2191","article-title":"HER2 reactivation through acquisition of the HER2 L755S mutation as a mechanism of acquired resistance to HER2-targeted therapy in HER2+ breast cancer","volume":"23","author":"Xu","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.nutres.2020.05.007_bb0235","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41392-019-0069-2","article-title":"Targeted therapeutic options and future perspectives for HER2-positive breast cancer","volume":"4","author":"Wang","year":"2019","journal-title":"Sig Transduct Target Ther"},{"issue":"1\u20133","key":"10.1016\/j.nutres.2020.05.007_bb0240","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejphar.2012.05.036","article-title":"Cycle arrest and apoptosis in MDA-MB-231\/Her2 cells induced by curcumin","volume":"690","author":"Sun","year":"2012","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"10.1016\/j.nutres.2020.05.007_bb0245","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.3892\/ijo.2016.3741","article-title":"Effect of curcumin and paclitaxel on breast carcinogenesis","volume":"49","author":"Quispe-Soto","year":"2016","journal-title":"Int J Oncol"},{"key":"10.1016\/j.nutres.2020.05.007_bb0250","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.phrs.2018.06.007","article-title":"The clinical efficacy of curcumin-containing nutraceuticals: an overview of systematic reviews","volume":"134","author":"Pagano","year":"2018","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.nutres.2020.05.007_bb0255","doi-asserted-by":"crossref","unstructured":"Q:Boots AW, Haenen GR, Bast A. Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol 2008; 585:325\u201337.","DOI":"10.1016\/j.ejphar.2008.03.008"},{"issue":"6","key":"10.1016\/j.nutres.2020.05.007_bb0260","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.joim.2018.07.001","article-title":"Bioavailable curcumin formulations: a review of pharmacokinetic studies in healthy volunteers","volume":"16","author":"Jamwal","year":"2018","journal-title":"J Integr Med"}],"container-title":["Nutrition Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0271531720304462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0271531720304462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T23:50:04Z","timestamp":1759449004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0271531720304462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":52,"alternative-id":["S0271531720304462"],"URL":"https:\/\/doi.org\/10.1016\/j.nutres.2020.05.007","relation":{},"ISSN":["0271-5317"],"issn-type":[{"value":"0271-5317","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lower concentrations of curcumin inhibit Her2-Akt pathway components in human breast cancer cells, and other dietary botanicals potentiate this and lapatinib inhibition","name":"articletitle","label":"Article Title"},{"value":"Nutrition Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nutres.2020.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}